Xiaohua Zeng

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Breast Cancer Cells

Tyrosine Kinase

Papillary Thyroid

Top Venues

Discover. Oncology

Cancer medicine

Disease markers

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Yuxin Huang, Guanwen Wang, Ningning Zhang, Xiaohua Zeng
MAP3K4 kinase action and dual role in cancer. Discover. Oncology 15 (1) (2024)
Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Yuxin Huang, Guanwen Wang, Ningning Zhang, Xiaohua Zeng
MAP3K4 kinase action and dual role in cancer. Discover. Oncology 15 (1) (2024)
Yuxin Huang, Guanwen Wang, Ningning Zhang, Xiaohua Zeng
MAP3K4 kinase action and dual role in cancer. Discover. Oncology 15 (1) (2024)
Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Xuemei Yao, Wei Li, Liqi Li, Menghuan Li, Youbo Zhao, De Fang, Xiaohua Zeng, Zhong Luo
YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis. Cell death & disease 13 (3) (2022)
Yixin Hu, Daihong Liu, Yongchun Deng, Feng Yu, Hong Yu, Yong Tan, Xiaoyu Zhou, Jiang Liu, Weiwei Lei, Xiaohua Zeng, Jiuquan Zhang
Changes in Degree Centrality and Functional Connectivity after the First Cycle of Neoadjuvant Chemotherapy in Newly Diagnosed Breast Cancer: A Longitudinal Study. Disease markers 2022 (2022)